Upgrade

Cognition Therapeutics, Inc.

CGTX

Last
$0.88
Day
-2.0%
1y
-54.1%
5y
-93.0%
52w
-56.3%
SPY YTD
+13.3%
XLV
+8.1%
Earnings
2026-11-0526d
EMA 21
0.95
EMA 50
0.99
EMA 200
1.10
20d high
-17.1%
5y high
-93.5%
5y range
5th
Website · 14 employees · United States

Positions held

Your positions

CGTX isn't in your positions.

Add it to see shares, cost, and P&L here.

Score
-24
Hold
avoid
Signal
Strong Sell
Target
$0.98
Stop
$0.82
Stop distance
6.5%
Target vs last
+11.8%

Fundamentals

Market cap$85.13MEnterprise value$51.70MTrailing P/E—Forward P/E-4.07
PEG—Price / book2.58Beta1.80Dividend yield0.00%
Revenue growth—Earnings growth—Gross margin0.0%Operating margin0.0%
Profit margin0.0%ROE-83.8%ROA-78.2%Debt / equity0.02
Current ratio7.03Free cash flow-$23.95MAnalyst recommendationstrong_buyMean target$3.33
52w high$2.0552w low$0.55

Quarterly

2026-Q22026-Q12025-Q42025-Q32025-Q22025-Q1
Revenue$0.0M$0.0M$0.0M$0.0M$0.0M—
Op margin——————
Net income-$3.9M-$4.6M-$3.3M-$4.9M-$6.7M—
Gross margin——————
Gross profit——————
Operating income-$4.2M-$4.8M-$3.7M-$5.2M-$6.9M—

Yearly (6y)

20252024202320222021
Revenue$0.0M$0.0M$0.0M$0.0M—
Op margin—————
Net income-$23.5M-$34.0M-$25.8M-$21.4M—
Gross margin—————
Gross profit—————
Operating income-$24.4M-$34.4M-$25.9M-$21.3M—
Headline scan

No flags

• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).

News

CGTX · daily-8.8% over 13 sessions
Close EMA21 EMA50 EMA200
0.880.920.961.001.042026-092026-092026-092026-092026-102026-102026-10
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin
-$7M-$5M-$3M-$2M$0M0%5%10%2025-Q22025-Q32025-Q42026-Q12026-Q2